Canaccord Genuity maintains a 'Buy' on Apple (AAPL); Checks Indicate Strong Sales Ahead of iPhone 5 Launch
Get Alerts AAPL Hot Sheet
Price: $305.93 +0.22%
Rating Summary:
44 Buy, 29 Hold, 9 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
44 Buy, 29 Hold, 9 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Apple (NASDAQ: AAPL) price target raised to $545.
Canaccord analyst, T. Michael Walkley, said, "Our August channel checks indicated strong sell-through trends for both the iPhone and iPad. Based on solid demand trends for iPhone/iPad, poor sell-through trends for competing tablet offerings, and the ramping iOS ecosystem driving longer-term replacement sales, we believe Apple will maintain dominant value share of both the tablet and smartphone markets to drive healthy long-term earnings growth...As a result, we are raising our 2011 pro forma EPS estimate from $26.37 to $27.29 and our 2012 estimate from $30.29 to $32.13."
For more ratings news on Apple click here and for the rating history of Apple click here.
Shares of Apple closed at $374.05 yesterday.
Canaccord analyst, T. Michael Walkley, said, "Our August channel checks indicated strong sell-through trends for both the iPhone and iPad. Based on solid demand trends for iPhone/iPad, poor sell-through trends for competing tablet offerings, and the ramping iOS ecosystem driving longer-term replacement sales, we believe Apple will maintain dominant value share of both the tablet and smartphone markets to drive healthy long-term earnings growth...As a result, we are raising our 2011 pro forma EPS estimate from $26.37 to $27.29 and our 2012 estimate from $30.29 to $32.13."
For more ratings news on Apple click here and for the rating history of Apple click here.
Shares of Apple closed at $374.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share